Your browser doesn't support javascript.
loading
Health-related quality of life in women with recurrent ovarian cancer receiving paclitaxel plus trebananib or placebo (TRINOVA-1).
Fujiwara, K; Monk, B J; Lhommé, C; Coleman, R L; Brize, A; Oaknin, A; Ray-Coquard, I; Fabbro, M; Provencher, D; Bamias, A; Vergote, I; DeCensi, A; Zhang, K; Vogl, F D; Bach, B A; Raspagliesi, F.
Afiliação
  • Fujiwara K; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Hidaka-Shi, Japan. Electronic address: fujiwara@saitama-med.ac.jp.
  • Monk BJ; University of Arizona Cancer Center at Saint Joseph's Hospital and Medical Center, Phoenix, USA.
  • Lhommé C; Gustave Roussy, Villejuif, France.
  • Coleman RL; Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
  • Brize A; Hematology & Chemotherapy, Riga East Clinical University Hospital, Riga, Latvia.
  • Oaknin A; Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Ray-Coquard I; Department of Medicine, Centre Léon Bérard and University Claude Bernard, Lyon.
  • Fabbro M; Medical Oncology, Institut Régional du Cancer Montpellier, Montpellier, France.
  • Provencher D; Department of Obstetrics and Gynecology, Centre Hospitalier de L'Université de Montreal Notre-Dame, Montreal, Canada.
  • Bamias A; Department of Clinical Therapeutics, Alexandra Hospital, Athens, Greece.
  • Vergote I; University Hospitals-KU Leuven, Leuven Cancer Institute, Leuven, Belgium.
  • DeCensi A; Medical Oncology, Ente Ospedaliero Ospedali Galliera, Genova, Italy.
  • Zhang K; Amgen Inc., Thousand Oaks, USA.
  • Vogl FD; Amgen Inc., Thousand Oaks, USA.
  • Bach BA; Amgen Inc., Thousand Oaks, USA.
  • Raspagliesi F; Surgery, Fondazione IRCCS Istituto Nazionale per la Cura e lo Studio dei Tumori, Milan, Italy.
Ann Oncol ; 27(6): 1006-1013, 2016 06.
Article em En | MEDLINE | ID: mdl-27029706
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteínas Recombinantes de Fusão / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Neovascularização Patológica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Proteínas Recombinantes de Fusão / Protocolos de Quimioterapia Combinada Antineoplásica / Paclitaxel / Neovascularização Patológica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2016 Tipo de documento: Article